ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 157 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2015. The put-call ratio across all filers is 0.97 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $41,000 | -38.8% | 62,766 | +2.1% | 0.00% | – |
| Q4 2021 | $67,000 | -58.1% | 61,472 | -30.2% | 0.00% | – |
| Q3 2021 | $160,000 | -26.9% | 88,117 | +6.2% | 0.00% | – |
| Q2 2021 | $219,000 | -29.1% | 82,983 | -3.3% | 0.00% | – |
| Q1 2021 | $309,000 | +45.1% | 85,801 | +1.1% | 0.00% | – |
| Q4 2020 | $213,000 | +30.7% | 84,902 | +31.5% | 0.00% | – |
| Q3 2020 | $163,000 | -29.4% | 64,573 | -8.1% | 0.00% | – |
| Q2 2020 | $231,000 | +87.8% | 70,302 | +39.9% | 0.00% | – |
| Q1 2020 | $123,000 | -44.3% | 50,260 | +7.3% | 0.00% | – |
| Q4 2019 | $221,000 | +16.9% | 46,844 | +6.2% | 0.00% | – |
| Q3 2019 | $189,000 | -19.6% | 44,107 | +9.3% | 0.00% | – |
| Q2 2019 | $235,000 | +63.2% | 40,341 | +8.1% | 0.00% | – |
| Q1 2019 | $144,000 | +105.7% | 37,316 | -0.4% | 0.00% | – |
| Q4 2018 | $70,000 | -51.0% | 37,464 | -16.0% | 0.00% | – |
| Q3 2018 | $143,000 | +22.2% | 44,623 | +14.4% | 0.00% | – |
| Q2 2018 | $117,000 | -28.7% | 38,990 | -6.8% | 0.00% | – |
| Q1 2018 | $164,000 | -5.2% | 41,854 | -0.2% | 0.00% | – |
| Q4 2017 | $173,000 | +38.4% | 41,957 | +105.8% | 0.00% | – |
| Q3 2017 | $125,000 | -16.7% | 20,386 | -15.2% | 0.00% | – |
| Q2 2017 | $150,000 | +5.6% | 24,046 | +7.5% | 0.00% | – |
| Q1 2017 | $142,000 | +18.3% | 22,373 | 0.0% | 0.00% | – |
| Q4 2016 | $120,000 | -2.4% | 22,373 | +2.6% | 0.00% | – |
| Q3 2016 | $123,000 | +5.1% | 21,806 | +2.0% | 0.00% | – |
| Q2 2016 | $117,000 | -22.0% | 21,388 | +5.5% | 0.00% | – |
| Q1 2016 | $150,000 | -9.1% | 20,264 | +2.1% | 0.00% | – |
| Q4 2015 | $165,000 | -5.7% | 19,851 | +2.3% | 0.00% | – |
| Q3 2015 | $175,000 | -15.9% | 19,404 | +12.2% | 0.00% | – |
| Q2 2015 | $208,000 | +47.5% | 17,292 | +32.1% | 0.00% | – |
| Q1 2015 | $141,000 | +27.0% | 13,089 | -52.5% | 0.00% | – |
| Q2 2014 | $111,000 | – | 27,534 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $60,394,000 | 3.07% |
| MSD Partners, L.P. | 3,410,500 | $21,213,000 | 1.32% |
| MILLER VALUE PARTNERS, LLC | 4,926,456 | $30,643,000 | 1.24% |
| Michael & Susan Dell Foundation | 66,749 | $415,000 | 0.33% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $933,000 | 0.26% |
| Piermont Capital Management Inc. | 85,500 | $532,000 | 0.15% |
| A.R.T. Advisors, LLC | 411,547 | $2,559,000 | 0.14% |
| EQUITEC PROPRIETARY MARKETS, LLC | 96,100 | $598,000 | 0.14% |
| Vident Investment Advisory, LLC | 204,744 | $1,274,000 | 0.10% |
| EQUITEC PROPRIETARY MARKETS, LLC | 68,800 | $428,000 | 0.10% |